Show simple item record

dc.contributor.authorParissis, Haralabos
dc.contributor.authorLeotsinidis, Michael
dc.contributor.authorAkbar, Mohammad Tauqeer
dc.contributor.authorApostolakis, Efstratios
dc.contributor.authorDougenis, Dimitrios
dc.date.accessioned2010-07-13T14:00:53Z
dc.date.available2010-07-13T14:00:53Z
dc.date.issued2010
dc.identifier.citationThe need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome. 2010, 5:20 J Cardiothorac Surgen
dc.identifier.issn1749-8090
dc.identifier.pmid20367880
dc.identifier.doi10.1186/1749-8090-5-20
dc.identifier.urihttp://hdl.handle.net/10147/107558
dc.description.abstractBACKGROUND: The early and intermediate outcome of patients requiring intraaortic balloon pump (IABP) was studied in a cohort of 2697 adult cardiac surgical patients. METHODS: 136 patients requiring IABP (5.04%) support analysed over a 4 year period. Prospective data collection, obtained. RESULTS: The overall operative mortality was 35.3%. The "operation specific" mortality was higher on the Valve population.The mortality (%) as per time of balloon insertion was: Preoperative 18.2, Intraoperative 33.3, postoperative 58.3 (p < 0.05).The incremental risk factors for death were: Female gender (Odds Ratio (OR) = 3.87 with Confidence Intervals (CI) = 1.3-11.6), Smoking (OR = 4.88, CI = 1.23- 19.37), Preoperative Creatinine>120 (OR = 3.3, CI = 1.14-9.7), Cross Clamp time>80 min (OR = 4.16, CI = 1.73-9.98) and IABP insertion postoperatively (OR = 19.19, CI = 3.16-116.47).The incremental risk factors for the development of complications were: Poor EF (OR = 3.16, CI = 0.87-11.52), Euroscore >7 (OR = 2.99, CI = 1.14-7.88), history of PVD (OR = 4.99, CI = 1.32-18.86).The 5 years survival was 79.2% for the CABG population and 71.5% for the valve group. (Hazard ratio = 1.78, CI = 0.92-3.46). CONCLUSIONS: IABP represents a safe option of supporting the failing heart. The need for IABP especially in a high risk Valve population is associated with early unfavourable outcome, however the positive mid term results further justify its use.
dc.language.isoenen
dc.subjectMEDICINEen
dc.subjectSURGERYen
dc.subject.meshAged
dc.subject.meshCardiac Surgical Procedures
dc.subject.meshChi-Square Distribution
dc.subject.meshCoronary Artery Bypass
dc.subject.meshCreatinine
dc.subject.meshFemale
dc.subject.meshHospital Mortality
dc.subject.meshHumans
dc.subject.meshIntra-Aortic Balloon Pumping
dc.subject.meshMale
dc.subject.meshRisk Assessment
dc.subject.meshRisk Factors
dc.subject.meshSurvival Rate
dc.subject.meshTreatment Outcome
dc.subject.otherCARDIOTHORACIC SURGERYen
dc.titleThe need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome.en
dc.contributor.departmentRoyal Victoria Hospital, Cardiothoracic Department, Belfast, Nothern Ireland. hparissis@yahoo.co.uken
dc.identifier.journalJournal of cardiothoracic surgeryen
refterms.dateFOA2018-08-22T08:24:06Z
html.description.abstractBACKGROUND: The early and intermediate outcome of patients requiring intraaortic balloon pump (IABP) was studied in a cohort of 2697 adult cardiac surgical patients. METHODS: 136 patients requiring IABP (5.04%) support analysed over a 4 year period. Prospective data collection, obtained. RESULTS: The overall operative mortality was 35.3%. The "operation specific" mortality was higher on the Valve population.The mortality (%) as per time of balloon insertion was: Preoperative 18.2, Intraoperative 33.3, postoperative 58.3 (p < 0.05).The incremental risk factors for death were: Female gender (Odds Ratio (OR) = 3.87 with Confidence Intervals (CI) = 1.3-11.6), Smoking (OR = 4.88, CI = 1.23- 19.37), Preoperative Creatinine>120 (OR = 3.3, CI = 1.14-9.7), Cross Clamp time>80 min (OR = 4.16, CI = 1.73-9.98) and IABP insertion postoperatively (OR = 19.19, CI = 3.16-116.47).The incremental risk factors for the development of complications were: Poor EF (OR = 3.16, CI = 0.87-11.52), Euroscore >7 (OR = 2.99, CI = 1.14-7.88), history of PVD (OR = 4.99, CI = 1.32-18.86).The 5 years survival was 79.2% for the CABG population and 71.5% for the valve group. (Hazard ratio = 1.78, CI = 0.92-3.46). CONCLUSIONS: IABP represents a safe option of supporting the failing heart. The need for IABP especially in a high risk Valve population is associated with early unfavourable outcome, however the positive mid term results further justify its use.


Files in this item

Thumbnail
Name:
20367880.pdf
Size:
499.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record